Lysophosphatidic acid receptor 5 in insular cortex as a potential analgesic target in neuropathic pain
Neuropathic pain remains a significant clinical challenge and existing treatments have limited efficacy and often over rely on opioids. Pharmacological inhibition and genetic knockout of lysophosphatidic acid receptor 5 (LPA5) lead to an analgesic effect on nerve injury-induced nociceptive hypersens...
Guardat en:
| Autors principals: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2025-09-01
|
| Col·lecció: | Neurotherapeutics |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S187874792500087X |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
